Clinical Trials Browser

Phase 1/2 × Withdrawn × ProMune × Clear all

NCT00226993 2016-12-01

Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides.

Phase 1/2 Withdrawn

Mycosis Fungoides